Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HSDT Helius Medical Technologies Inc

-0.20 (-3.03%)
Last Updated: 09:35:08
Delayed by 15 minutes


Draw Mode:

Volume 54
Bid Price 6.35
Ask Price 6.88
News -
Day High 6.41


52 Week Range


Day Low 6.41
Company Name Stock Ticker Symbol Market Type
Helius Medical Technologies Inc HSDT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.20 -3.03% 6.41 09:35:08
Open Price Low Price High Price Close Price Prev Close
6.41 6.41 6.41 6.61
Trades Volume Avg Volume 52 Week Range
5 54 - 5.69 - 20.95
Last Trade Time Type Quantity Stock Price Currency
09:34:40 5 $ 6.70 USD

Helius Medical Technologies Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.68M 708.25k - 787k -14.07M -19.87 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Helius Medical Technolog... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No HSDT Message Board. Create One! See More Posts on HSDT Message Board See More Message Board Posts

Historical HSDT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.507.006.016.457,291-0.09-1.38%
1 Month7.557.886.016.666,191-1.14-15.1%
3 Months8.8210.996.018.0524,946-2.41-27.32%
6 Months7.7514.445.699.19471,787-1.34-17.29%
1 Year15.0020.955.6911.78482,338-8.59-57.27%
3 Years789.601,700.005.6970.48683,796-783.19-99.19%
5 Years15,505.0018,672.505.69520.13551,688-15,498.59-99.96%

Helius Medical Technolog... Description

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.

Your Recent History

Delayed Upgrade Clock